Tumor cell-intrinsic PD-1 receptor is a tumor suppressor and mediates resistance to PD-1 blockade therapy

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-03-11

DOI: 10.1073/pnas.1921445117

Affiliations: 10

Authors: 24

Go to article
Institutions Share
Shanxi Academy of Advanced Research and Innovation (SAARI), China 0.33
CAS Key Laboratory of Bio-Medical Diagnostics, SIBET CAS, China 0.29
CAS Key Laboratory of Pathogenic Microbiology and Immunology, IM CAS, China 0.13
The People's Hospital of SND, China 0.08
School of Life Sciences, USTC, China 0.04
Guangdong Provincial Key Laboratory of Epigenetics and Gene Regulation of Malignant Tumor, SYSU, China 0.04
Department of Thoracic Surgery II at Beijing Cancer Hospital, PKU, China 0.02
MOE Key Laboratory of Carcinogenesis and Translational Research at Beijing Cancer Hospital, PKU, China 0.02
Department of Medical Molecular Biology, AMMS, China 0.02
Collaborative Innovation Center for Cancer Medicine, China 0.02

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER